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Acronyms and abbreviations 
BAO       = Basilar artery occlusion  
CT      = Computed tomography 
DNT       = Door to needle time  
EMS        = Emergency medical service 
EVT       = Endovascular thrombectomy 
FAST       = Face-Arm-Speech-Time 
GSH        = Groote Schuur Hospital 
HSFSA   = Heart and Stroke foundation of South Africa  
HREC     = Human Research and Ethics Committee  
IVT       = Intravenous thrombolysis  
NNT      = Number needed to treat 
MR      = Magnetic resonance 
RCT      = Randomized controlled trial 
SA       = South Africa 
Definitions of terms  
Door-to-needle time = time interval from arrival at emergency department (ED) to the 
administration of intravenous thrombolysis 
Door-to-CT brain time = time interval from arrival at ED to CT brain.  
Symptom-to-door time = time interval from symptom onset to arrival at ED.  
Symptom-to-needle time = time interval from symptom onset to the administration of 
thrombolysis 
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ABSTRACT 
Title  
Barriers to acute stroke care at a tertiary Hospital in the Western Cape.  
Background  
Stroke guidelines recommend treatment of acute stroke as a medical emergency. In many 
countries prolonged delays occur before patients with acute stroke receive medical attention. 
Only a small percentage of patients are assessed in hospital within the time window for 
reperfusion therapy. There is limited available published data concerning barriers to acute 
stroke care in South African patients. The aim of this study was to determine the pre-hospital 
barriers and in-hospital delays to emergency care for patients presenting to Groote Schuur 
Hospital (GSH) with acute stroke. 
Methods 
Eligible patients included were those with a clinical and radiological diagnosis of acute stroke 
who presented to GSH Emergency Unit and required admission for more than 24 hours. The 
study was a prospective, observational study with two components: a semi structured 
interviewer administered questionnaire and a record review of ischaemic stroke patients’ 
clinical notes within 48 hours of admission to GSH. GSH is a tertiary/academic level hospital 
in Cape Town, Western Cape province, South Africa. Recruitment took place over a 6-week 
period. 
Results  
Demographics: 50 patients were included, with a median age of 61,5 (IQR 44,7 – 70,2) years; 
gender: females, 29 (58%). Ethnicity: Mixed African ancestry 38 (76%), Black 11 (22%).  
Pre- hospital barriers: The median distance to hospital was 12,7 (IQR 10,2 – 17,6) km. Most 
patients 32 (64%) called for assistance immediately. Frequent reasons cited for delays: waiting 
for improvement, 7 (38,9%) and failure of symptom recognition 4 (22%). Most patients used 
their own private transport, 32 (64%) and half of the patients (25) presented directly to GSH.  
In- hospital delays: The median time interval from arrival at the Emergency Unit to doctor 
assessment for all the patients was 67,5 (IQR 19,75 – 128,5) minutes. The median door to CT 
brain time interval for all patients was 5,1 (IQR 1,7 – 10,2) hours and 3,1 (IQR 0,8 – 9,6) 
hours for those patients that arrived within the thrombolysis time window. Only 21 of 50 
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patients were referred and assessed by the stroke unit team. Only 3 of the 21 patients received 
intravenous thrombolysis and none received mechanical thrombectomy. 
Conclusion:  
There majority of the patients who arrived at GSH early after symptom onset used their own 
private transport and lived close to hospital. Pre-hospital barriers were failure to recognize 
symptoms, patients hoping for clinical improvement, delays in ambulance transport and 
routing via secondary hospitals. In hospital delays were prolonged door to doctor assessment 
and door to CT Brain time intervals.  
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INTRODUCTION 
Acute ischemic stroke should be treated as a medical emergency and evaluated with minimum 
delay, regardless of severity of deficits. Time loss due to pre-hospital and in-hospital delays 
remains a problem especially for patients that are potential candidates for reperfusion therapy 
including intravenous thrombolysis and or endovascular therapy (EVT). Reperfusion therapy 
is more effective when given early after symptom onset. Brain tissue is very sensitive to 
ischemia, and neurons begin to die shortly after oxygen deprivation. The benefit of reperfusion 
therapy is strongly time dependent and all efforts should be made to initiate reperfusion 
therapy as soon as possible. Many patients that could potentially benefit from this type of 
treatment are precluded due to prolonged pre-hospital and in-hospital delays.  
 
There has been limited progress in management of stroke patients in developing countries and 
data on stroke care in these countries is sparse. Stroke guidelines are continuously developed 
and updated in the high-income countries but their applicability for use in developing regions 
is questionable. The number of stroke patients receiving hyper-acute stroke care including the 
option of intravenous thrombolysis in developing countries is very low. The objective of this 
study is an assessment of pre-hospital and in-hospital barriers and limitations to hyper-acute 
stroke care at a tertiary hospital in the Western Cape of South Africa. 
 
The study methodology is a prospective, observational evaluation of 50 ischaemic stroke 
patients admitted to Groote Schuur Hospital (GSH) Emergency Unit (EU) over a period of six 
weeks. Most of the patients admitted to our hospital are either Black or of mixed African 
ancestry from lower income groups, many living in informal settlements. Pre-hospital barriers 
to early treatment that were assessed included failure of symptom recognition, delay in calling 
for help, emergency medical service (EMS) response, distance to the hospital and delays due 
to routing via community health centers (CHC) and secondary hospitals without availability 
of reperfusion therapy for suitable patients with acute ischemic stroke. 
 
The in- hospital delays that were evaluated included the efficiency of the triage process for 
stroke patients and delays in obtaining the required mandatory investigations such as CT brain 
scan that could potentially result in suitable patients being precluded from receiving 
reperfusion therapy within the acceptable time window after symptom onset.  
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By identifying the causes of pre and in-hospital delays to acute stroke care, data from this 
study will be used to address and improve existing pathways to overcome these barriers. If 
these delays can be significantly reduced, this should impact positively on hyper-acute stroke 
care in our hospital potentially leading to improved outcomes for our stroke patients.   
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PART A : Structured Literature Review 
1. Epidemiology of stroke  
Stroke is a clinical syndrome with rapid onset of focal neurological symptoms due to no other 
apparent reason but a vascular one, leading to permanent brain tissue damage (Albers et al., 
2002). Stroke is the second-leading cause of death worldwide after ischemic heart disease 
(Lozano et al., 2012). In 2010, stroke was responsible for 5.3 million deaths or 1 in 10 deaths 
worldwide and the absolute number of people affected by stroke has been increasing yearly 
since 1990, along with the numbers of disabled stroke survivors and deaths related to stroke 
(Krishnamurthi et al., 2013). More than 80% of stroke burden occurs in low and middle-income 
countries (LMICs), yet reliable data on stroke epidemiology, particularly incidence and 
morbidity is scarce in these settings (Sajjad et al., 2013). In South Africa (SA), stroke is 
responsible for some 25,000 deaths annually and 95,000 people lived with disability, yet few 
published studies report on the epidemiology of stroke in rural parts of the country. We do not 
know the incidence of stroke in South Africa, but we do have some data on stroke mortality 
and prevalence that highlight the impact of stroke on the population (Connor et al., 2007).  
 
2. Time is brain concept 
The phrase “time is brain” emphasizes that human nervous tissue is rapidly and irretrievably 
lost as stroke progresses and that any therapeutic interventions should be emergently pursued 
(Gomez et al., 1993). Recent advances in stroke neuroimaging permit an estimate calculation 
of the quanta of brain tissue that is lost per unit time in acute ischemic stroke. The average 
duration of non-lacunar stroke evolution is 10 hours (range 6 to 18 hours), and the average 
number of neurons in the human forebrain is 22 billion. In patients experiencing a typical large 
vessel acute ischemic stroke, it is estimated that 120 million neurons, 830 billion synapses, and 
714 km (447 miles) of myelinated fibers are lost each hour. In each minute, 1.9 million neurons, 
14 billion synapses, and 12 km (7.5 miles) of myelinated fibers are destroyed. Quantitative 
estimates of the pace of neural circuitry loss in human ischemic stroke emphasize the time 
urgency of stroke care (Saver et al., 2006). A recent study attempted to estimate the potential 
beneficial effect over a patient’s lifetime of rapid initiation of stroke thrombolysis in suitable 
patients with acute ischemic stroke. The authors estimated that each minute of time saved from 
symptom onset-to-treatment conferred on average 1.8 days of extra healthy life and each 15-
minute decrease in treatment delay could provide an average equivalent of 1 month of 
additional disability-free life (Meretoja et al., 2014).  
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3. Stroke management  
Recognition of stroke symptoms by the patient at risk, family members, the general public, and 
health workers is an important factor that determines a prompt response and initiation of 
management. Given the narrow time window for reperfusion therapy, patients with symptoms 
should seek urgent medical attention. Paramedics should be able to recognize symptoms and 
signs of stroke and diagnose stroke using simple instruments such as the Face-Arm-Speech-
Time test, FAST (Nor et al., 2004). If it is feasible to transport a stroke patient to a hospital 
with the appropriate resources, expertise, and protocols in place for reperfusion therapy within 
the recommended time interval for such treatment, then the patient should be transferred 
directly to such a stroke centre. Ideally EMS personnel should be able to provide pre-hospital 
notification to the receiving hospital that a suspected stroke patient is on route so that the 
appropriate hospital resources may be mobilized before patient arrival. The key to reducing in-
hospital delays is to do as little as possible after the patient has arrived at the emergency room 
and as much as possible before that, while the patient is being transported (Meretoja et al., 
2012). In the emergency unit, stroke patients should be promptly identified, stabilised and 
evaluated urgently including receiving an urgent CT brain scan. Eligible patients for 
reperfusion therapy within the time window for treatment (with no contra-indications) should 
be promptly informed of both the potential benefits and the risks of this type of treatment so 
that a decision can be made whether to proceed with such treatment as the potential benefits 
for both intravenous thrombolysis and endovascular therapy is time-dependent (“time” is quite 
literally “brain” and the sooner the treatment is given after symptom onset, the greater the 
chance of a successful outcome). 
3.1 Prehospital management of stroke 
According to the most recent American Stroke Association guidelines, protocols should be 
used to guide pre-hospital stroke care (Powers et al., 2018). These concerns maintaining 
physiological homeostasis and management of early complications or co-morbidities of stroke, 
such as impaired consciousness, seizures and vomiting or hemodynamic instability. General 
measures by an attending physician or paramedic include assessment of breathing and 
maintaining the airway (providing oxygen if necessary, to maintain saturation over 95%), 
managing hemodynamic instability, and maintaining hydration (patients should receive nil by 
mouth until swallowing has been assessed to prevent aspiration). Blood glucose should be 
measured, and hypoglycemia should be promptly treated if present. The information 
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concerning the history of event, including time of onset, signs and symptoms, and previous 
medical, drug and social history should be obtained from patient and/or informant. All 
medication should be brought to hospital with the patient and the informant should be 
encouraged to accompany the patient.  
 
3.2 Emergency medical service (EMS) 
Emergency medical service (EMS) refers to the full scope of pre-hospital stroke care, 
ambulance activation and dispatch, emergency medical response, triage and stabilization in the 
field, ground or air ambulance transport. The EMS threshold of stroke suspicion should be set 
low, to be sensitive rather than specific, as the final diagnosis will be made at the admitting 
hospital and an initially delayed diagnosis can prevent a patient from receiving effective 
therapy (Meretoja et al., 2012). EMS personnel should obtain information from the patient, 
family members, or other witnesses about the suspected stroke event (presenting symptoms, 
time of onset or time of symptom recognition or time last known well, and sequence of events) 
as well as information concerning comorbid conditions, current medications, and any formal 
or informal advance directives that may influence care by EMS and in the emergency 
department (ED). EMS personnel should provide pre-hospital notification to the receiving 
hospital that a suspected stroke patient is en route so that the appropriate hospital resources 
may be mobilized before patient arrival. (Bryer et al., 2010) Pre-notification to the admitting 
hospital with a stroke service by the EMS has been shown to reduce in-hospital delays, improve 
intravenous thrombolysis rates, reduce lengths of hospital stays and mortality, and is 
recommended both in the American and European stroke guidelines (Adams et al., 2007). Each 
potential stroke patient should be evaluated as an emergency similar to myocardial infarction 
or trauma and ambulances should be dispatched with high priority (Casaubon et al., 2015).  
 
3.3. Radiology  
Ideally, every patient with stroke should have a brain imaging study (CT brain or MRI brain 
scan) to confirm the stroke and exclude stroke mimics although this is not feasible in all South 
African hospitals because of logistic and resource constraints. Non-contrast CT brain scan is 
the most cost-effective strategy for imaging acute stroke patients (Wardlaw et al., 2004). At 
our center we have a CT scan available on site 24 hours a day and a dedicated stroke response 
service and can offer reperfusion therapy including both intravenous thrombolysis and 
endovascular therapy for appropriate patients with ischemic stroke who arrive within 
therapeutic window. Urgent brain imaging is required and mandatory to rule out brain 
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haemorrhage as this cannot reliably be predicted clinically and is an absolute contra-indication 
to reperfusion therapy.  
 
Some centers prefer to use MRI scan as first-line routine investigation for acute stroke, but CT 
scan is more readily accessible and available at most stroke centres and has the advantage of a 
quicker scanning time. Diffusion-weighted MRI (DWI) is more sensitive than CT brain for 
detection of early ischemic changes. (Ay et al., 2002).  
 
With the advent of endovascular therapy (mechanical thrombectomy) being available at our 
centre, vascular imaging with CT angiography is used to identify the site of a proximal arterial 
obstruction suitable for an intra-arterial intervention. Advanced CT or MRI imaging (such as 
perfusion diffusion mismatch) has been shown to be of value in selecting patients for 
reperfusion beyond the current time intervals but is not widely available in SA. (Nogueira et 
al., 2018). Whichever radiologic modality is used to select patients, time to initiate reperfusion 
therapy remains of the essence with better outcomes associated with earlier intervention 
following onset of stroke symptoms. This further emphasizes the need for rapid assessment 
and treatment of acute ischemic stroke (AIS).  
 
4. Reperfusion therapy  
Rapid, safe and effective arterial recanalization to restore blood flow and improve functional 
outcome remains an objective of hyper-acute ischemic stroke management (Bryer et al., 2010). 
Successful recanalization has the potential to ameliorate many complications and the need for 
rehabilitation, but is attempted in only few ischemic stroke patients, mostly due to failure of 
the patient and the healthcare system to respond rapidly enough (Meretoja et al., 2012). 
Prevention is the key to reduce the burden of stroke but once it fails, reperfusion therapy in 
selected patients is the only acute medical treatment shown to reduce the brain damage and 
improve patient outcomes (Ringleb et al., 2008). Ideally patients with disabling acute ischemic 
stroke should be screened without delay by a physician with stroke expertise to determine 
eligibility for both medical treatment with intravenous recombinant tissue plasminogen 
activator (IV r-tPA) within 4·5 h from stroke symptom onset and or endovascular therapy 
(EVT) within a six-hour window from stroke symptom onset for ischemic stroke patients with 
proven proximal large artery occlusions (Casaubon et al., 2015) . All eligible patients should 
receive reperfusion therapy as soon as possible after hospital arrival, with a target door-to-
needle time of less than 60 minutes. Treatment should be initiated as soon as possible after 
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patient arrival following brain imaging. Every effort should be made to ensure door-to-needle 
times are routinely monitored and improved.  
 
This narrow window of opportunity and low levels of awareness about stroke and inefficient 
public transport systems represent the largest obstacle to more widespread use of reperfusion 
treatment. These and other issues, such as cost, expertise, and the availability of required 
resources necessary to administer this type of treatment, have caused concerns that intravenous 
thrombolysis may not be a viable option for treating stroke in many developing countries 
(Wasserman et al., 2012). 
4.1 Intravenous thrombolysis 
Intravenous thrombolytic therapy with recombinant tissue plasminogen activator (IV r-tPA) is 
an accepted therapy for acute ischemic stroke within 4.5 hours of onset (Bluhmki et al., 2009). 
Intravenous thrombolysis should be administered at a hospital with rapid triage of stroke 
patients, established protocols for use of IV r-tPA, where there is strict adherence to inclusion 
and exclusion criteria, and where good post-treatment care is available. Thrombolytic therapy 
should only be given if the diagnosis is established by a physician with expertise in the 
diagnosis of stroke and who is aware of the risks of this treatment. Imaging of the brain (CT 
scan or MRI) must be done prior to treatment with IV r-tPA and assessed by physicians with 
expertise in reading and interpreting the imaging study and when hemorrhage is excluded.  
The landmark National Institute of Neurological Disorders and Stroke (NINDS) rt-PA trial in 
the USA in 1995 demonstrated that patients receiving this intervention were 30% more likely 
to survive with minimal disability resulting in a 12% absolute increase in the proportion having 
excellent functional outcomes at 3 months. IV r-tPA at a standard dose given within 4,5 hours 
after ischemic stroke onset, significantly improves clinical outcome, compared with placebo 
(Hacke et al., 2008). Treatment benefit is time-dependent, and the number needed to treat 
(NNT) to get one more favorable outcome drops from 4 during the first 90 minutes through to 
7 at 3 hours, and towards 14 between 3 and 4.5 hours. The sooner the treatment is given, the 
greater the chance of a successful outcome. (Hacke et al., 2008). A recent meta-analysis has 
shown that irrespective of age or stroke severity, and despite an increased risk of fatal 
intracranial haemorrhage during the first few days after treatment, intravenous thrombolysis 
significantly improves the overall odds of a good stroke outcome when delivered within 4·5 h 
of stroke onset, with earlier treatment associated with bigger proportional benefits. (Emberson 
et al., 2014). Meretoja and others demonstrated that minutes saved in stroke thrombolysis 
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translate to days, weeks, and months of disability-free life over a patient’s lifetime. Therefore, 
all attempts should be made to reduce treatment delays (Meretoja et al., 2014).  
 
4.2 Endovascular therapy 
Until recently, the only licensed treatment for acute ischemic stroke was intravenous 
thrombolysis with recombinant tissue-plasminogen activator (IV r-tPA). The net benefit of IV 
r-tPA for patients with severe stroke due to large proximal artery occlusion is reduced 
compared to more distal occlusions. Early recanalization generally occurs in less than 30% of 
patients with internal carotid, proximal middle cerebral artery or basilar artery occlusions 
(Bhatia et al., 2010) with good clinical outcome occurring in less than 25% of patients with 
proximal occlusions when treated with IV r-tPA alone (Fischer et al., 2005). Important 
independent risk factors predicting poor outcome post intravenous thrombolysis are the length 
and location of the arterial thrombus. (Hirano et al., 2010) The reduced efficacy of intravenous 
thrombolysis in the treatment of proximal occlusions with a larger clot burden treatment led to 
efforts to remove larger arterial clots using mechanical means.  
 
The recent publication of several clinical trials evaluating the effect of mechanical 
thrombectomy in patients with ischemic strokes due to proximal occlusions in the anterior 
circulation have demonstrated that the procedure can accelerate the process of recanalization, 
increase the recanalization rate and improve outcomes in such patients. These findings have 
revolutionized the care of patients with acute ischemic stroke due to large vessel occlusion in 
comprehensive stroke centres where interventional procedures such as mechanical 
thrombectomy can be performed. These RCTs showed that endovascular therapy (EVT) had a 
clinical benefit when it was performed within 6 hours after the onset of stroke symptoms 
(Berkhemer et al., 2015). Data from recent clinical trials indicate that the use of intravenous 
thrombolysis with r-tPA within 4,5 hours combined with EVT within 6 hours is superior to IV 
r-tPA alone (Campbell et al., 2015) for proximal occlusions amenable to endovascular therapy 
as demonstrated by CT or MR angiography. The efficacy of this treatment in suitable patients 
surpasses any previous therapy in stroke medicine, with a number needed to treat of less than 
3 for improved functional outcome. EVT has recently become available at GSH by year 2016 
as part of the stroke service and is a collaborative effort between the stroke unit, neurosurgery, 
and radiology. However, only a very small minority of stroke patients in South Africa are likely 
to qualify for EVT at present, given the availability of the required expertise, time constraints 
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for treatment, resource limitations, lack of comprehensive stroke units, all of which are barriers 
to hyper-acute stroke care.(Bryer et al., 2010).  
 
5. Acute stroke care in developing countries 
Despite robust evidence of efficacy of reperfusion therapy for suitable patients with acute 
ischemic stroke we have encountered relatively few patients that present to GSH Emergency 
Unit early enough after symptom onset to potentially benefit from revascularization therapies 
such as intravenous thrombolysis and or endovascular therapy, and to receive appropriate 
treatment to maintain physiologic homeostasis and prevent early complications. Bryer and 
Wasserman assessed the short-term outcomes and safety of intravenous r-tPA for the treatment 
of stroke at Groote Schuur Hospital and only identified 42 patients in 11 years (Bryer et al., 
2012). As with many other low and middle-income countries, most patients in our setting 
experience prolonged delays between symptom onset and access to acute stroke care. 
Consequently, only a small proportion of stroke patients admitted to our hospital are potentially 
suitable candidates for revascularization therapy. If specific barriers to emergency care of 
stroke patients are identified and addressed, more patients could benefit from this type of 
treatment in conjunction with standard treatment with measures directed at maintaining 
physiological homeostasis and preventing early complications could be implemented earlier.  
 
Khalema and colleagues (2018) undertook a retrospective record review of all patients who 
presented with clinical features of stroke to a tertiary academic emergency department (ED) in 
Johannesburg, South Africa, from 01 January to 31 December 2014. Their aim was to 
investigate the time from stroke symptom onset to presentation to the ED, the time from arrival 
to CT scan acquisition and the potential influencing factors. Patients presenting with stroke 
were identified through the ED triage and patient registers, as well as the radiology department 
CT reports. They included 232 eligible stroke patients. The median time to presentation to the 
ED was 33 hours with the majority of patients (81.3%) presenting after the 4.5 hours window 
for thrombolysis. The median time to CT was 8 hours. Only 3.9% of patients had a CT scan 
within one hour of arrival and none of the patients were thrombolysed. They concluded that, 
the majority of patients presented late to hospital. Their presentation time to ED almost 
parallels other low- and middle-income countries like Nigeria and China but is lower than in 
developed countries like England (<3 h presentation rate of 39.5%) and Australia (31.3% 
presenting within 4.5 h). Additionally, the majority of their patient population had a CT scan 
performed after 1 hour from ED arrival – this is longer than the  
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25-minute recommendation by the American Heart Association. 
Wasserman and colleagues (2009) assessed discharge planning of stroke patients, available 
resources and continuity of care between hospital and community in a remote rural setting in 
South Africa. They sought to determine outcomes, family participation and support needs, and 
implementation of secondary prevention strategies. A trained field worker using a structured 
questionnaire assessed thirty consecutive stroke patients from the local hospital clinically at 
time of discharge and re-assessed 3 months after discharge in their homes. All patients were 
discharged into family care as there was no stroke rehabilitation facility available to the 
community. Of the 30 patients recruited, 20 (66.7%) were alive at 3 months, 9 (30%) had died, 
and 1 was lost to follow-up. The 3-month mortality rate was high. Most survivors improved 
functionally but were left with significant disability. The authors recommended measures to 
improve family education and the level of home-based care to reduce the degree of functional 
disability in rural stroke patients. 
Pandian and colleagues (2017) performed a systematic review on strategies to improve stroke 
care services in low- and middle-income countries (LMICs). They were attempting to 
determine the quality of existing stroke-care services in LMICs and to highlight indigenous, 
inexpensive, evidence- based implementable strategies being used in stroke-care. They 
concluded that some strategies are economic, feasible and reproducible but remain untested 
and that data on their outcomes and sustainability is limited.  
A multi-site, hospital-based survey was conducted in 11 major hospitals in Ghana from 
November 2015 to April 2016. They aimed to identify and evaluate available acute stroke 
services in Ghana and the extent to which these services align with global best practice. A pre-
tested, structured questionnaire was used to gather data on available hospital-based acute stroke 
services in the study sites, using The World Stroke Organisation Global Stroke Services 
Guideline as a reference for global standards. Their study confirmed previous reports of limited 
and variable provision of evidence-based stroke services and the low priority for stroke care in 
resource poor settings. The authors recommended health policy initiatives to enhance uptake 
of evidence based acute stroke services in order to reduce stroke-related mortality and 
morbidity in countries such as Ghana. (Baatiema et al., 2017).  
Baatiema and colleagues (2017) undertook a systematic search of the published literature to 
identify and compare evidence-based acute stroke management interventions with alternative 
care on overall patient mortality and morbidity outcomes, functional independence, and length 
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of hospital stay across Africa. Eligible studies were abstracted into evidence tables and their 
methodological quality appraised using the Joanna Briggs Institute checklist. Only four non-
experimental studies (three cohort and one case series studies) were included in the final 
review. One study focused on the clinical efficacy of a stroke unit whilst the remaining three 
reported on thrombolytic therapy. The results demonstrated a reduction in patient deaths 
attributed to stroke unit care and thrombolytic therapy. However, the limited number of eligible 
studies and methodological limitations compromised definitive conclusions on the extent of 
and level of efficacy of evidence-based acute stroke care interventions across Africa. Evidence 
from this review confirms the widespread assertion of low applicability and uptake of evidence-
based acute stroke care in low- and middle-income countries (LMICs). Despite the limited 
number of eligible studies, the overall positive patient outcomes following such interventions 
demonstrate the applicability and value of evidence-based acute stroke care interventions in 
Africa. 
Urimubenshi and colleagues (2018) acknowledged the limited availability of stroke services in 
African countries. They aimed to describe the status of stroke care in Africa. They undertook 
a systematic search of the published literature to identify recent publications that described 
stroke care in any African country. They included 38 publications representing 14 of the 54 
African countries. This review provides an overview of stroke care in Africa and highlights the 
paucity of available data. Poor awareness of stroke signs and symptoms, shortages of medical 
transportation, health care personnel, and stroke units, and the high cost of brain imaging, 
thrombolysis, and outpatient physiotherapy rehabilitation services were reported as major 
barriers to providing best-practice stroke care in Africa.  
6. Barriers to hyper-acute stroke care  
Regarding reperfusion therapy, several obstacles need to be overcome in order to reduce the 
symptom-to-needle time (arrival to emergency department (ED) to the administration of 
thrombolysis). Most time is lost in the pre-hospital period, the so-called “symptom-to-door 
time”, largely because many patients tend to wait before they seek medical attention. However, 
this is difficult to accomplish because campaigns aimed at raising public awareness of stroke 
symptoms have only limited impact on behaviour. (Van Wijngaarden, 2009) Within the 
hospital the focus should be on decreasing the time from arrival to intravenous thrombolysis 
(IVT) administration, the so-called “door-to needle time” (DNT). Besides improved functional 
outcome, a reduction in the DNT would increase the proportion of patients eligible for IVT 
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allowing more patients to be treated within the 4.5-hour time period from onset of symptoms 
(Kruyt, 2013).  
As the benefits of IVT in acute ischemic stroke are time dependant, guidelines recommend an 
arrival to treatment initiation time or door to needle time (DNT) < 60 minutes. A multicentre 
study conducted in 1082 hospitals in the United States collected data of acute ischemic stroke 
patients treated with tPA within 3 hours of symptom onset between April 1, 2003, to September 
30, 2009. Of the 25504 ischemic stroke patients that were treated with intravenous tPA, the 
DNT time was < 60 minutes in only 6790 (26.6%) (Fannorrow et al., 2011). Patient factors 
most strongly associated with DNT of less than 60 minutes were younger age, male gender, 
white race, or no prior stroke. Hospital factors associated with less than 60-minute DNT 
included greater annual volumes of tPA-treated stroke patients. The proportion of patients with 
DNT of less than 60 minutes varied widely by hospital participating in this study (0% to 79.2%) 
and increased overall from 19.5% in 2003 to 29.1% in 2009. Symptomatic intracranial 
haemorrhage after treatment with tPA was less frequent for patients with door-to-needle times 
< 60 minutes compared with patients with door-to-needle times > 60 minutes (4.7% versus 
5.6%). The authors concluded that less than one-third of the patients treated with intravenous 
tPA had a DNT of less than 60 minutes, with only modest improvement occurring over the 6.5 
year period. They recommended a targeted initiative in order to improve the timelines of 
reperfusion treatment in acute ischemic stroke. 
Meretoja and others analysed the effect of interventions aimed to reduce treatment delays in 
their single-center observational study in Finland. They included a total of 1,860 patients 
treated between June 1995 and June 2011, which also included 174 patients with basilar artery 
occlusion (BAO) treated mostly beyond 4.5 hours from symptom onset. In the non-BAO 
patients, there was a progressive reduction in the DNT annually, from a median of 105 minutes 
in 1998, to 60 minutes in 2003 and a further reduction to a mean of 20 minutes in 2011. They 
concluded that with multiple concurrent strategies it was possible to reduce the median in-
hospital delay to 20 minutes. In order to achieve this objective, they proposed that much of the 
initial assessment could be done while the patient was being transported to hospital with less 
time spent in the emergency unit (EU) (Meretoja et al., 2012).  
7. Benefits of stroke unit care  
A stroke unit is a dedicated and geographically defined part of a hospital that takes care of 
stroke patients in both the acute and immediate post-acute phase. It has specialized staff with 
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a coordinated multidisciplinary expert approach to treatment and care. It comprises core 
disciplines: medical, nursing, physiotherapy, occupational therapy, speech and language 
therapy, and social work (Langhorne, 1998). An essential component of the stroke unit model 
of care is established pathways and management protocols for acute and post-acute 
management of stroke (including pre-hospital and emergency unit management of stroke) with 
careful attention to active management of physiological abnormalities to maintain homeostasis. 
Stroke care is coordinated by multi-disciplinary team (MDT) with regular scheduled ward 
rounds attended by the full MDT to discuss management strategy for each patient. 
 
Patients treated in stroke units have been shown to have a better outcome than those treated in 
general wards. Meta-analyses of controlled trials indicate that treating patients in stroke units 
reduces mortality, institutionalization, and dependency. Treatment in a stroke unit compared 
with treatment in a routine clinical setting has been shown in studies to reduce mortality as well 
as reduce the likelihood of dependency after stroke and institutionalization. (Langhorne P 1993; 
Cochrane Database Syst Rev 2002; Stroke Unit Trialists’ Collaboration 1997 and 2002; 
Seenan, 2007). Stroke unit care incorporates many elements working together, and it is difficult 
to identify any specific factor responsible for better outcome. 
 
Very few studies have assessed the efficacy of stroke unit care in developing countries. A local 
study documented the outcome of patients admitted to the first multidisciplinary stroke unit 
opened at a secondary hospital in Cape Town, South Africa. Patient outcomes including in-
hospital mortality, resource utilization (length of hospital stay, CT brain scans performed, and 
tertiary hospital referral). Access to inpatient rehabilitation were recorded for all patients 
admitted to the hospital for 3 months before initiating multi- disciplinary stroke care and for 3 
months after implementing multidisciplinary stroke care. Despite the limitations of the study, 
the authors demonstrated that multidisciplinary stroke care could be successfully implemented 
in a resource-constrained secondary-level hospital with a significant reduction in inpatient 
mortality and an increase in referrals for inpatient rehabilitation suggesting an overall 
improvement in stroke care.(deVilliers., 2009) Resource utilization in terms of length of 
hospital stay increased by a mean of 2 days but the number of CT brain scans performed and 
referral to a tertiary hospital did not increase significantly in this study. Several other studies 
from low-income countries on five continents that compared care in a discrete stroke ward with 
conventional care in a general ward noted lower death rates in the stroke-unit group than in the 
control group. Despite using various methodological approaches, the difference was 
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statistically significant for many of these studies. These findings show that stroke units outside 
high-income areas can improve outcomes, at least in terms of survival (Langhorne, 2012).  
 
Ideally all stroke patients should be treated in a stroke unit. A stroke unit was established in the 
year 2000 at Groote Schuur hospital (GSH) Western Cape, South Africa and offers a 24-hour 
service for evaluation and treatment of acute stroke cases including those suitable for 
reperfusion therapy with intravenous thrombolysis and more recently for endovascular 
mechanical thrombectomy. 
 
All types of stroke patients, and not only those suitable for reperfusion therapy, benefit from 
treatment in a stroke unit. The sooner the patient is treated after symptom onset with measures 
to maintain homeostasis and prevent complications the better the likelihood for a good outcome 
which provides good cause to strive to reduce the barriers to acute care regardless of whether 
the stroke patient is a potential candidate for reperfusion therapy. 
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ABSTRACT 
Background  
Stroke guidelines recommend treatment of acute stroke as a medical emergency. In many countries 
prolonged delays occur before patients with acute stroke receive medical attention. Only a small 
percentage are assessed in hospital within the time window for reperfusion therapy. There is limited 
available published data concerning barriers to acute stroke care in South African patients. 
Aims  
To determine the pre-hospital barriers and in-hospital delays to emergency care for patients presenting 
to Groote Schuur Hospital (GSH) with acute stroke. 
Methods 
Study setting and design:                            
GSH is a tertiary academic level hospital in Cape Town, Western Cape province, South Africa. This 
study was a prospective, observational study with two components: a semi structured interviewer 
administered questionnaire and a record review of ischaemic stroke patients’ clinical notes within 48 
hours of admission to GSH. 
  
Study-population: 
Eligible patients were those with a clinical and radiological diagnosis of acute stroke who presented to 
GSH emergency unit and required admission for more than 24 hours. Recruitment took place over a 6-
week period. 
Results  
Demographics: 50 patients were included, with a median age 61,5 (IQR 44,7 – 70,2) years; gender: 
females, 29 (58%). Ethnicity: Mixed African ancestry 38 (76%), Black 11 (22%).  
Pre- hospital barriers: The median distance to hospital was 12,7 (IQR 10,2 – 17,6) km. Most patients 
32 (64%) called for assistance immediately. In the 18 patients who delayed seeking assistance, the two 
most common reasons for the delays were: waiting for improvement 7 (38,9%), and failure of symptom 
recognition 4 (22%). Most of the patients 32 (64%) used their own private transport and half (25) of 
patients presented directly to GSH.  
In- hospital delays: The median arrival at emergency unit to doctor assessment time interval for all the 
patients was 67,5 (IQR 19,75 – 128,5) minutes. Median door to CT brain time interval for all patients 
was 5,1 (IQR 1,7 – 10,2) hours and 3,1 (IQR 0,8 – 9,6) hours for those patients that arrived within 
thrombolysis window. Only 21 of 50 patients were referred to and assessed by the stroke unit. Only 3 
of the 21 patients received intravenous thrombolysis and none received mechanical thrombectomy for 
the duration of the study. 
Conclusion:  
Most of the patients who arrived early at GSH used their own transport and lived close to hospital. Pre-
hospital barriers were failure to recognize symptoms, patients hoping for improvement, delays in 
ambulance transport and routing via secondary hospitals. In hospital delays were prolonged door to 
doctor assessment and door to CT Brain time intervals.  
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BACKGROUND 
Stroke guidelines recommend treatment of acute stroke as a medical emergency. In many 
countries prolonged delays occur before patients with acute stroke receive medical attention. 
Consequently, only a small percentage are assessed in hospital within the time window for 
reperfusion therapy. There is limited available published data concerning barriers to acute 
stroke care in South African patients. 
AIMS AND OBJECTIVES 
The aim of the study was to determine both the pre-hospital barriers and the in-hospital delays 
to emergency care for patients presenting to Groote Schuur Hospital (GSH) with acute stroke. 
The overall objective of the study was to prospectively assess a group of patients that present 
to GSH Emergency Unit with clinical and radiological evidence of acute stroke (irrespective 
of whether or not they presented within the therapeutic window for the re-vascularization 
therapy) in order to identify and determine the factors that resulted in either early arrival or 
prolonged delays following the onset of stroke symptoms.  
STUDY RATIONALE  
Data from this study could provide valuable information relating to any pre-hospital and in-
hospital barriers to the emergency care of patients presenting to GSH with acute stroke. 
Information from this study could be used to advise on methods of improving pathways to 
overcome these barriers.  
METHODS 
Study setting and design  
Groote Schuur Hospital has a 6-bed stroke unit and offers a 24-hour stroke response service 
for evaluation and treatment of acute stroke cases including all those patients suitable for 
reperfusion therapy with intravenous thrombolysis and more recently for endovascular 
mechanical thrombectomy. The Stroke Service evaluates patients with the diagnosis of stroke 
in the Emergency Unit and consults on similar patients in the hospital inpatient service and 
admits stroke patients directly to the 6 bed Stroke Unit located within the neurology ward. The 
Stroke Service roster with the names and contact details of the registrars and consultants on 
stroke call is available in the Emergency Unit and through the Hospital telephone exchange. 
The initial evaluation is conducted by the Emergency Unit physicians who can refer any stroke 
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patient to the registrar on call from the stroke response team. Given the limited number of beds 
in the stroke unit, admissions tend to favour patients who have suffered stroke with a prior 
good baseline and are considered to have good rehabilitation potential, young patients with no 
clear cause for stroke, or older patients with no clear risk factors, and those stroke patients with 
management difficulties. All such patients with acute stroke admitted to the Stroke Unit are 
evaluated according to established pathways and follow a schedule of diagnostic and 
therapeutic steps. When the Stroke Unit is full, the Emergency Unit will refer the patient to the 
medical registrar on call for further management in the general medical wards. The stroke unit 
team can continue to review the patient in the medical ward if required but all stroke patients 
suitable for reperfusion therapy, those patients with acute posterior fossa infarcts or 
haemorrhage, and those presenting to the EU with recent TIA are required to be assessed and 
followed up by the stroke response team regardless of whether or not a bed is available in the 
stroke unit. 
 
This study was a prospective observational study over a 6-week period with two components: 
a semi structured interviewer administered questionnaire and a record review of ischemic 
stroke patients’ clinical notes within 48 hours of admission to hospital. The questionnaire was 
administered by face-to-face interviews by the investigator with each participant and/or their 
closest relatives presenting with acute stroke within 48 hours of arrival to the GSH emergency 
unit. The objectives of the questionnaire were to assess the pre-hospital barriers to acute stroke 
care and the variables of this assessment are listed in table 1. 
Table 1 
Assessment of pre-hospital barriers to care:  
Demographic data (age, gender, ethnicity, employment status, marital status, living alone, 
level of education, distance to GSH) 
Time and date of onset of symptoms of stroke  
Time interval between symptom onset to calling for assistance for transfer to hospital 
Reason for delay in calling for assistance 
Mode of transport to hospital 
Time interval from calling for assistance to vehicle arrival  
Transit time to GSH 
Direct or indirect route of transfer to GSH (ie. direct to GSH or indirect route via intermediate 
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Community Health Centre or level 2 hospital) 
If indirect, transit time to intermediate hospital 
Delay interval at level of the intermediate hospital  
Time interval between symptom onset of acute stroke and arrival at GSH  
 
After the interviews were completed, a review of the participants’ clinical notes was undertaken 
by the first author within 48 hours of the patients’ admission to hospital in order to assess any 
in-hospital barriers to care. The variables for this review are listed in table 2. 
Table 2  
Assessment of in-hospital barriers to care: 
Time interval between patient arrival in the EU and initial assessment by triage-nurse 
Time interval between onset of symptoms and initial doctor assessment 
Triage grade  
Time interval between onset of symptoms and stroke service assessment. 
Time interval between patient arrival in the EU and CT Brain scan completed.  
Door to needle time for intravenous thrombolysis (where applicable) 
Door to needle time for endovascular revascularization (where applicable) 
Onset of stroke to needle time 
 
Study population: 
Eligible patients for inclusion in this study were those with a clinical and radiological diagnosis 
of acute stroke who presented to the emergency unit and that required admission for more than 
24 hours. Every attempt was made to assess patients sequentially within 24 hours of being 
admitted avoiding selection bias. Convenience sampling was used considering timeframe as 
the main factor in order to obtain our sample size from stroke patients visiting the GSH 
emergency unit. Recruitment took place over a 6-week period and a convenient sample of 50 
patients was selected.  
Exclusion Criteria 
Patients for whom the time of onset of stroke could not be reliably determined (for example 
aphasic patients or those whose relatives are unable to provide onset time), and those patients 
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presenting with subarachnoid haemorrhage and other stroke mimics were excluded from the 
study. 
Data collection:  
All data was collected by the first author over a 6-week period between July 2017 to mid-
August 2017. Patients admitted to the GSH Emergency Unit with the clinical and radiological 
diagnosis of acute stroke were invited to participate in a face to face interview. These interviews 
were conducted by the first author in English, Xhosa, or Afrikaans with a translator. 
Participants were interviewed in a comfortable secluded area in the emergency unit, medical 
ward, or stroke unit and only one interview was conducted for each participant. Responses 
from the questions were transcribed onto the questionnaire form during the interview. The 
responses from these questionnaires were used to determine the prehospital barriers to acute 
stroke care. After the face to face interview with each participant (or close relative if patient 
was aphasic) had been completed, an audit of each patient’s medical record was undertaken by 
the first author within the first 48 hours of the patient’s admission to assess the in-hospital 
delays to acute stroke care. Patients were initially identified using the nurses’ patient admission 
record book and the investigator confirmed the diagnosis by review of the clinical records 
following admission to the emergency unit and by clinical assessment (the first author is a 
member of the stroke team which responds to stroke referrals from the emergency unit). All 
data from the hospital record and clinical assessment was recorded on a data capture sheet 
(refer appendix 1) and entered on a spreadsheet for analysis. 
Data analysis: 
The data from the questionnaire and from the medical record was analysed separately. The 
categorical data has been summarized using frequency tables and descriptive data, such as the 
reason for the delay in calling for assistance, has been categorized. For the numerical data the 
means, standard deviations, medians and interquartile ranges were used to summarize the data 
and the decision about which measures were used was determined by the distribution of the 
data. Analysis of the data was conducted using standard statistical software SPSS 
(https://www.ibm.com/analytics/spss-statistics-software).  
Ethical considerations: 
This study was reviewed and approved by the University of Cape Town’s Human Research 
Ethics Committee (HREC REF: 879/2016). The study was a prospective, observational study 
and did not involve any active treatment or intervention. There were no potential health or 
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safety risks associated with the study. Informed consent was obtained from all participants and 
personal information remained confidential and confined to the data capture sheet that was 
stored in a secure place. No participant identifiers were present in the dissertation or any 
publications that may arise from this study. Computerized data bearing patient identifiers was 
password protected. Investigators stated no conflict of interest and no external source of 
funding was sought. The study adheres to the declaration of Helsinki 2000. 
RESULTS 
The demographic data: the median (IQR) age of the cohort was 61,5 (44,7 – 70,2) years, figure 
1. Gender distribution showed more females, 29 (58%) than males, 21 (42%). There was a 
predominance of Mixed African ancestry patients 38 (76%), followed by Black patients 11 
(22%), and 1 (2%) Indian patient. The majority of patients had secondary school education 33 
(66%), followed by those with primary school education 15 (30%), and only a minority of 
patients 2 (4%) had tertiary level education. The majority of patients were un-employed, 37 
(74%) at the time of their stroke.  
Pre- hospital delays: The median (IQR) distance to hospital was 12,7 (10,2 – 17,6) km. The 
majority of patients indicated that they had called for assistance immediately 32 (64%) after 
symptom onset. For the 18 patients who delayed seeking medical attention immediately after 
symptom onset, 7 (38,9%) patients had hoped and were waiting for clinical improvement, 4 
(22%) failed to recognise that their presenting symptoms were due to stroke, 6 (33,4%) were 
alone and aphasic and unable to communicate and summon help at onset of their symptoms, 
and 1 patient reported that she had concealed her symptoms as she did not wish to be a burden 
to her family. The majority of patients in this cohort used their own transport, 32 (64%) to get 
to hospital. Half (25) of patients presented directly to GSH and arrived earlier within a median 
(IQR) of 2,5 (1,75 – 4,55) hours of symptom onset compared to the indirect group that routed 
via a secondary hospital and presented within a median (IQR) of 24,1 (7,7 – 44,0) hours. 
 
Figure 1: Box plot of age 
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In- hospital delays: All the stroke patients were triaged code orange irrespective of the time 
interval between symptom onset and their arrival at hospital. Triage grade orange requires 
urgent (but not immediate) management with a target of less than 10 minutes. The median 
(IQR) time interval from arrival at GSH (entrance security stamp) to assessment by the triage 
nurse was 6.0 (0-20,5) minutes. The median (IQR) time interval from arrival at GSH to the EU 
doctor assessment for all 50 patients was 67,5 (19,75– 128,5) minutes. The median (IQR) time 
interval from arrival to EU doctor assessment was 19 (5,5 – 81) minutes for the 23 patients that 
arrived within less than 4,5 hours of symptom onset. A CT brain scan was performed for all 
patients within a median (IQR) time interval of 5,1 (1,7 – 10,2) hours from arrival in the EU, 
but the 23 patients that arrived within less than 4,5 hours of symptom onset had an earlier CT 
brain scan within a median (IQR) time interval of 3,1 (0,8 – 9,6) hours after arrival in the EU. 
The 27 patients that arrived in more than 4,5 hours after symptom onset were scanned within 
a median (IQR) time interval of 5,3 (3,0 – 9,7) hours after arrival.  
Of the 50 patients that were admitted to GSH with acute stroke, 21 (42%) were referred to the 
stroke service and were assessed by the stroke service within a median (IQR) time interval of 
2,0 (1,4 – 10,2) hours after their arrival in the EU. Twelve of these patients arrived within less 
than 4,5 hours from symptom onset and were assessed by the stroke service within a median 
(IQR) time interval of 1,47 (0,8 – 1,8) hours of arrival in the EU. The remaining 9 patients that 
arrived more than 4,5 hours after symptom onset were assessed by the stroke service within a 
median (IQR) time interval of 11,9 (9,8 – 14,4) hours of arrival. These were typically non-
urgent referrals to the stroke service requesting advice on further work-up or management or 
admission to the stroke unit when a bed became available. Only 3 of the 21 patients referred to 
the stroke response team received intravenous thrombolysis and none received mechanical 
thrombectomy. 
 
 
 
 
 
 
 
 
 
 
 37 
 
DISCUSSION 
The most consistently reported pre-hospital barrier in this study was the patient’s or family’s 
poor knowledge of stroke and stroke presentation which delayed their request for urgent 
medical help. This seems to be comparable with data from other developing countries. Surveys 
have shown that many people do not know the presenting symptoms of stroke (Weltermann et 
al., 2000). Several patients in this study had hoped and were waiting for clinical improvement 
after symptom onset or simply failed to recognise that their presenting symptoms were due to 
stroke whereas others were alone and aphasic at symptoms onset and unable to call for 
assistance. The majority of patients had no tertiary education, and most were unemployed at 
time of their stroke and lived-in low-income areas including informal settlements which are 
some distance from the hospital. Most patients did, however, called for assistance immediately 
but due to ambulance delays, most patients used their own private transport to get to hospital. 
Half of patients presented directly to our hospital, but the remainder routed via a secondary 
hospital (without capacity to undertake any form of reperfusion therapy) with resultant delay 
in symptom onset to arrival time at our hospital. For the reasons cited above, most patients 
presented to our hospital outside the window of opportunity for reperfusion treatment. 
  
The in-hospital delays that were identified included a delay in the time interval between arrival 
at the emergency unit (EU) and doctor assessment time which was more than an hour for all 
patients despite the code orange triage allocation. However, the median arrival time to EU 
doctor assessment time interval was 19 minutes for those patients that arrived within less than 
4,5 hours of symptom onset. Notably, there was delay in the arrival to CT brain scan time 
interval of more than 5 hours for all patients. Those patients that arrived within the reperfusion 
therapy time window had an earlier CT brain scan done with a median time interval from arrival 
of just over 3 hours which is nevertheless excessively long given the time constraints critical 
to good outcomes with reperfusion therapies. Patients that present outside the reperfusion 
therapy window are not processed immediately. This study has also identified significant 
delays in door to CT Brain pathways likely caused by delays in nursing triage, delays in EU 
doctor assessment, delays in CT Brain booking, reliance on hospital porters to transfer patient 
to and from CT scanner, and hurdles in prioritizing stroke patients with other cases including 
trauma cases.  
Only 21 (42%) of the 50 patients in this study were referred to the stroke service and they were 
assessed by the stroke service within a median time interval of 2,0 hours after their arrival in 
 38 
 
the EU and those 12 patients that arrived within the therapeutic time window for reperfusion 
treatment were assessed by the stroke service within a median time interval of 1,47 hours of 
arrival in the EU leaving much scope for improvement in reaction times.  
Limitations of this study were the relatively small sample size of 50 patients from a single 
centre and the limited recruitment time period of 6 weeks that is likely to have introduced a 
degree of selection bias. Although patients were recruited sequentially, some stroke patients 
that were referred from a secondary hospital for a CT brain scan were then immediately 
transferred back to these hospitals and were not included in the study. Acquisition of the data 
pertaining to the prehospital barriers to care relied on the patient or family member being able 
to give an accurate reliable account of the time of symptom onset and reasons for any delay in 
calling for assistance at the time of the onset of acute stroke symptoms. Clearly the pre and in-
hospital delays and barriers to stroke care identified in this study at our institution are not 
necessarily a reflection of stroke care access and level of care available at other hospitals in the 
region.  
 
In the Cape Town metropole there are 2 established stroke units at tertiary hospital with the 
necessary expertise and resources to offer reperfusion therapy for suitable patients with acute 
ischemic stroke. This prospective observational study has identified some of the important pre-
hospital and in-hospital barriers that will need to be addressed and overcome if reperfusion 
therapy is to be delivered more effectively, efficiently and equitably at specialized stroke 
centres. According to our knowledge this is the first study that attempts to identify barriers to 
hyper-acute stroke care in South Africa at a state hospital where such resources are available.  
 
The sooner the patient is treated after symptom onset with measures to maintain homeostasis 
and prevent complications the better the likelihood for a good outcome providing good cause 
to strive to reduce the barriers to acute care regardless of whether the stroke patient is a potential 
candidate for reperfusion therapy. 
Regarding reperfusion therapy which is available at Groote Schuur Hospital for suitable 
patients with ischaemic stroke, the phrase “time is brain,” emphasizes that human nervous 
tissue is rapidly and irretrievably lost as stroke progresses and that therapeutic interventions 
should be emergently pursued (Gomez et al., 1993). The patient is estimated to lose 
approximately 1.9 million neurons each minute in untreated ischemic stroke (Saver et al., 
2006). All guidelines emphasize rapid, safe and effective arterial recanalization to restore blood 
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flow through intravenous r-tPA and or endovascular therapy and improving functional outcome 
remains a primary objective of hyper-acute ischemic stroke management (Bryer et al., 2010). 
Treatment benefit is time-dependent and the sooner the treatment is given, the greater the 
chance of a successful outcome. The number needed to treat (NNT) to get one more favorable 
outcome drops from 4 within the first 90 minutes after symptom onset through to 7 at 3 hours, 
and towards 14 between 3 and 4.5 hours (Hacke et al., 2008).  
 
Several obstacles need to be identified and overcome to reduce delays in treating patients with 
ischemic stroke. Much time is lost in the pre-hospital period in the so-called “symptom-to-door 
time”, largely because many patients tend to wait before they seek medical attention. However, 
this is difficult to accomplish because campaigns aimed at raising public awareness of stroke 
symptoms have only limited impact on behaviour (Van Wijngaarden, 2009). Within the 
hospital the focus should be on decreasing the time from arrival to commencement of treatment. 
Stroke patients who spend hours waiting to be assessed in the EU are more likely dehydrate or 
aspirate potentially resulting in poorer outcomes. For those who are suitable for reperfusion 
therapy, a reduction in the door-to needle time (DNT) or door to arterial puncture time could 
lead to improved functional outcome and an increase in the proportion of patients eligible for 
IVT allowing more patients to be treated within the 4.5hour time period from onset of 
symptoms (Kruyt, 2013).  
 
Despite robust evidence of efficacy of reperfusion therapy for suitable patients with acute 
ischemic stroke we have encountered relatively few patients that present to GSH Emergency 
Unit early enough after symptom onset to potentially benefit from revascularization therapies 
such as intravenous thrombolysis and or endovascular therapy, and to receive early appropriate 
treatment to maintain physiologic homeostasis and prevent complications. As with many other 
low- and middle-income countries, the majority of patients in our setting experience prolonged 
delays between symptom onset and access to acute stroke care. Consequently, only a small 
proportion of stroke patients admitted to our hospital are potentially suitable candidates for 
revascularization therapy. If specific barriers to emergency care of stroke patients are identified 
and addressed, more patients could benefit from this type of treatment and measures directed 
at maintaining physiological homeostasis and preventing early complications could be 
implemented earlier. 
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Pre-hospital barriers to hyper-acute stroke care require attention as several studies have shown 
that public awareness programs reduce pre-hospital delays, but mass media campaigns, usually 
aimed at helping patients to identify the symptoms of stroke and the need to urgently call for 
help, are expensive and must be periodically repeated (Ringleb, 2008). The Heart and Stroke 
Foundation of South Africa has a crucial role to play in informing the broader South African 
public concerning recognition of symptoms of stroke and appropriate response to such 
symptoms. The Foundation actively promotes cardiovascular health through advocacy, 
influencing policy, providing information, tools, and support which will enable people to adopt 
healthy lifestyles and seek appropriate care early in the manifestations of the disease.  
In many metropolitan areas, including Cape Town, the Emergency Medical Services (EMS) 
are under-resourced and over-burdened with volume and load of patients that they manage and 
transport. If more people are to benefit from acute stroke care, then it is essential to engage 
with the EMS to explore ways in which stroke patients can be identified more easily and 
promptly such as the use of FAST. FAST stroke is an algorithm used to help identify and 
enhance the response to a person having an acute stroke. (Goldstein et al., 2005) The acronym 
stands for Facial drooping, Arm weakness, Speech difficulties and Time of onset and to call 
emergency services. The FAST algorithm was developed in the UK in 1998 by a group of 
stroke physicians, ambulance personnel, and an emergency department physician and was 
designed to be an integral part of a training package for ambulance staff. FAST was created to 
expedite administration of reperfusion therapy. The EMS personnel could be enabled to 
identify stroke signs in a patient and the time of onset of symptoms and then determine whether 
the patient could feasibly be transported to one of the two tertiary hospitals in the metropole 
within a time window to allow for the option of reperfusion therapy. In such an instance the 
EMS could ideally give pre-hospital notification to the stroke centre of the pending arrival of 
such a patient and avoid routing via a secondary hospital. Pre-hospital notification could enable 
rapid alerting of the stroke response team while patient is still in transit to EU and significantly 
reduce the arrival to assessment time interval by the stroke service. For those patients arriving 
with private transport, the stroke response team should be notified of the presence of the stroke 
patient in the EU prior to the CT brain scan request so that a more rapid scan is facilitated by 
the stroke team as a means of reducing the arrival to CT brain scan time interval. In many 
stroke centres reperfusion with intravenous r-tPA takes place in the scanner by the stroke team. 
Other measures to overcome in-hospital barriers to stroke care include implementing pragmatic 
protocols and pathways with flow diagrams of acute stroke care for the emergency unit that 
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includes stroke triage. Simulation training is a means to identify delays and improve the 
efficiency of the emergency pathways and stroke protocol at a stroke centre. DNT was 
shortened in all 5 stroke centers participating in simulation studies in the Czech Republic. 
(Svobodova et al., 2018) Simulation training has been shown to be a powerful tool for 
improving hospital logistics. Ongoing training of stroke unit and emergency department 
medical and nursing staff in acute stroke care remains an essential component of any measures 
aimed at improving management.  
More high-quality studies are needed to better understand barriers to acute stroke care in South 
Africa where resources are limited. This study has identified significant delays in both pre and 
in-hospital acute stroke management and highlights the need for improvement in stroke 
management pathways. This can be achieved by further training of the emergency services 
personnel (including staff managing the call-centres) on how to identify patients with acute 
stroke and those that are potential candidates for reperfusion treatment who can then be 
transferred directly to the appropriate hospital with a stroke service. The stroke team together 
with the emergency unit medical, triage, and nursing personnel at hospitals with a stroke 
service are also likely to benefit by regular stroke training including simulation training (such 
training is offered by the Angels Initiative in South Africa) in order to develop a more efficient 
acute stroke care pathway and standard operating procedure aimed at reducing treatment 
delays. Once such interventions have been implemented a further study would be of value to 
determine the efficacy of the intervention at the facility. 
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Appendix 1 : Data collection sheet 
 
PARAMETERS PATIENT DETAILS TIME IN MINUTES 
1ST name   
Surname   
Folder number   
Age    
Date of birth   
Gender    
Ethnicity   
Level of education    
Address    
Distance to hospital   
Employment Y/N   
Mobile 1   
Mobile 2   
Mobile 3   
Date of stroke   
Time of stroke   
Time interval to calling 
assistance for transfer to 
Hospital 
  
Reason for delay   
Mode of transport   
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Time interval from calling 
assistance to vehicle arrival 
  
Transit time to GSH   
Direct or indirect to GSH   
name of intermediate hospital   
Symptom onset to arrival at 
intermediate hospital 
  
Symptom onset to arrival at 
GSH (door) 
  
Triage grade   
Arrival to assessment time -
nurse 
  
Arrival to assessment time-
doctor 
  
Onset to doctor assessment time    
Arrival to stroke service 
assessment time 
  
Symptom onset to stroke 
service assessment time 
  
CT Brain Y/N               
Date CT Brain   
Time of CT Brain   
Door to CT Brain time   
Door to needle time –ivi tPA   
Symptom onset to ivi tPA time   
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Reason for not receiving 
thrombolysis 
  
Door to needle time -EVT   
Symptom onset to EVT time   
 
